Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejca.2020.05.026 http://scihub22266oqcxt.onion/10.1016/j.ejca.2020.05.026 32544799!7269953!32544799     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Cancer 2020 ; 135 (ä): 62-65 Nephropedia Template TP {{tp|p=32544799|t=2020. Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 |pdf=|usr=}}{{32544799}} gab.com Text Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 JO: Eur J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32544799 #FOAvip While confirmed cases of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease's damage. Although no proven effective therapies for treating patients with COVID-19 or for managing their complications currently exist, the rapidly expanding knowledge regarding severe acute respiratory syndrome coronavirus 2 and its interplay with hosts provides a significant number of potential drug targets and the potential to repurpose drugs already tested in other diseases. Herein, we report the biological rationale of immune-activating drugs and a brief summary of literature data on the potential therapeutic value of immune checkpoint inhibitors that have been recently tested beyond cancer treatment for their potential to restore cellular immunocompetence. Twit Text FOAVip Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 ????Eur J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32544799 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32544799 #FOAvip English Wikipedia <ref>{{Cite pmid|32544799}}</ref> Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 #MMPMID32544799 Di Cosimo S; Malfettone A; Perez-Garcia JM; Llombart-Cussac A; Miceli R; Curigliano G; Cortes J Eur J Cancer 2020[Aug]; 135 (ä): 62-65 PMID32544799show ga While confirmed cases of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease's damage. Although no proven effective therapies for treating patients with COVID-19 or for managing their complications currently exist, the rapidly expanding knowledge regarding severe acute respiratory syndrome coronavirus 2 and its interplay with hosts provides a significant number of potential drug targets and the potential to repurpose drugs already tested in other diseases. Herein, we report the biological rationale of immune-activating drugs and a brief summary of literature data on the potential therapeutic value of immune checkpoint inhibitors that have been recently tested beyond cancer treatment for their potential to restore cellular immunocompetence. |Antibodies, Monoclonal, Humanized/pharmacology/therapeutic use[MESH] |Apoptosis/drug effects/immunology[MESH] |B7-H1 Antigen/antagonists & inhibitors/immunology[MESH] |Betacoronavirus/immunology/*pathogenicity[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/blood/*drug therapy/immunology/virology[MESH] |Host-Pathogen Interactions/drug effects/immunology[MESH] |Humans[MESH] |Immunologic Factors/pharmacology/*therapeutic use[MESH] |Lymphopenia/blood/drug therapy/immunology/virology[MESH] |Neoplasms/blood/*drug therapy/immunology[MESH] |Pandemics[MESH] |Pneumonia, Viral/blood/*drug therapy/immunology/virology[MESH] |Programmed Cell Death 1 Receptor/antagonists & inhibitors/immunology[MESH] |Randomized Controlled Trials as Topic[MESH] |SARS-CoV-2[MESH] |T-Lymphocytes/drug effects/immunology[MESH]Immune checkpoint inhibitors: a physiology-driven approach to the trea(epmc).pdf DeepDyve Pubget Overpricing